Physician profile
Daniel S Durrie
NPI 1952305526
$974,481.43
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $12K · 2021: $889 · 2022: $9,147 · 2023: $210K · 2024: $726K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $935K · Consulting Fee: $1,225 · Food and Beverage: $203 · Travel and Lodging: $40.71.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $934,709.40 |
| Consulting Fee | $1,225.00 |
| Food and Beverage | $202.79 |
| Travel and Lodging | $40.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rxsight INC | $934,709.40 | 2023-2024 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Contact Lens |
| Johnson & Johnson Surgical Vision, INC. | $34,211.70 | 2019-2022 | |
| Avedro INC. | $2,750.00 | 2019 | |
| Alcon Vision LLC | $1,445.37 | 2019-2023 | Acrysof Iq Panoptix Uv Iol |
| Alcon Research LLC | $700.00 | 2021 | |
| Carl Zeiss Meditec, INC. | $358.06 | 2019-2023 | Lumera 700, Artevo 800 |
| Staar Surgical Company | $161.81 | 2019 | |
| Beaver-Visitec International, INC. | $73.55 | 2021 | |
| Bausch & Lomb Americas INC. | $47.48 | 2022 | |
| Novartis Pharmaceuticals Corporation | $24.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$171,370.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Durrie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.